27.04.2013
- Last year was operationally very successful for the Bayer Group. All three subgroups achieved sales gains and raised underlying earnings. So that the stockholders benefit from this...
17.04.2013
- Pharmaceutical company Actavis said on Tuesday that it would once again sell a generic version of Bayer's Yaz after an appeals court ruled that Bayer's patent for the oral...
11.04.2013
- The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...
08.04.2013
- Brenntag Schweizerhall, the chemical distributor's Swiss subsidiary, is pleased to announce a co-operation with Bayer CropScience and Infrapark Baselland. Brenntag will invest into...
02.04.2013
- Swiss specialty chemicals group Clariant International acquired the nano-silver ink technology platform developed under the trademark Bayink from Bayer (Germany). The transaction...
02.04.2013
- India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...
27.03.2013
- Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...
27.03.2013
- Bayer has appointed Dr. Markus Steilemann (42) as the new head of its Polycarbonates business unit. He succeeds Michael Koenig, who will join the Board of Management of Bayer on...